ZYBT (Zhengye Biotechnology Holding Limited Class A Ordinary Shares) Stock Analysis - AI Report

Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) is a publicly traded Healthcare sector company. As of May 21, 2026, ZYBT trades at $0.88 with a market cap of $43.74M and a P/E ratio of 0.00. ZYBT moved +0.00% today. Year to date, ZYBT is -22.78%; over the trailing twelve months it is -88.54%. Its 52-week range spans $0.68 to $14.30. Rallies surfaces ZYBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on ZYBT?

Rallies AI research for ZYBT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

ZYBT Key Metrics

Key financial metrics for ZYBT
MetricValue
Price$0.88
Market Cap$43.74M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$14.30
52-Week Low$0.68
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ZYBT News

ZYBT Analyst Consensus

ZYBT analyst coverage data. Average price target: $0.00.

Common questions about ZYBT

What is the AI research view on ZYBT?
Rallies AI research for ZYBT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for ZYBT?
Rallies AI research for ZYBT combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is ZYBT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ZYBT. It does not provide personalized investment advice.
ZYBT

ZYBT